Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis
Bikesh K. Nirala, Taku Yamamichi, Jason T. Yustein
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11367-11367
Open Access | Times Cited: 16

Showing 16 citing articles:

New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma
Cong Luo, Xiaoyun Min, Danying Zhang
Frontiers in Immunology (2025) Vol. 15
Open Access
7-Geranyloxycoumarin modulated metastatic potential of osteosarcoma cells via interaction with MMPs and JAK1/2
Fatemehsadat Hosseini, Abdolreza Ahmadi, Zahra Nasiri Sarvi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Untangling the Role of MYC in Sarcomas and Its Potential as a Promising Therapeutic Target
Fabio Sias, Stefano Zoroddu, Rossana Migheli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1973-1973
Open Access
Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis
Bikesh K. Nirala, Taku Yamamichi, D. Isabel Petrescu, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5108-5108
Open Access | Times Cited: 13
Cryoprotective isoliquiritigenin-zein phosphatidylcholine nanoparticles inhibits breast cancer-bone metastasis by targeting JAK-STAT signaling pathways
Kumar Ganesan, Cong Xu, Chunguang Xie, et al.
Chemico-Biological Interactions (2024) Vol. 396, pp. 111037-111037
Closed Access | Times Cited: 3
Regulation of bone homeostasis: signaling pathways and therapeutic targets
Zebin Wu, Wenming Li, Kunlong Jiang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 3
Perfluorooctane sulfonate-induced Sertoli cell injury through c-Jun N-terminal kinase: a study by RNA-Seq
Sheng Gao, Zifeng Chen, Xiaolong Wu, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 2, pp. C291-C309
Closed Access | Times Cited: 2
Amicis Omnia Sunt Communia: NF-κB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity
Mariana Medeiros, Sophia Guenka, David Bastos, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 734-734
Open Access | Times Cited: 1
Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
Weilin Shao, Yan Feng, Jin Huang, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Ubiquitination in osteosarcoma: unveiling the impact on cell biology and therapeutic strategies
Jianlin Shen, Yue Lai, Yanjiao Wu, et al.
Cancer Biology and Medicine (2024) Vol. 21, Iss. 10, pp. 880-897
Open Access | Times Cited: 1
PNO1 promotes the progression of osteosarcoma via TGF-β and YAP/TAZ pathway
Fang Long, Baolong Wang, Zengkun Yang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
The OSR9 Regimen: A New Augmentation Strategy for Osteosarcoma Treatment Using Nine Older Drugs from General Medicine to Inhibit Growth Drive
Richard E. Kast
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15474-15474
Open Access | Times Cited: 3
Research Progress of Non Coding RNA Related to Notch Signaling Pathway in Osteosarcoma
文强 李
Advances in Clinical Medicine (2024) Vol. 14, Iss. 02, pp. 3011-3017
Closed Access
Anti-tumor Effects of the eIF4A Inhibitor Didesmethylrocaglamide and Its Derivatives in Human and Canine Osteosarcomas
Janet L. Oblinger, Jack C. Wang, Georgia D. Wetherell, et al.
Research Square (Research Square) (2024)
Open Access
Anti-tumor effects of the eIF4A inhibitor didesmethylrocaglamide and its derivatives in human and canine osteosarcomas
Janet L. Oblinger, Jack C. Wang, Georgia D. Wetherell, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
The role of neutrophils in osteosarcoma: insights from laboratory to clinic
Ming Xia, Yu Han, Lihui Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Page 1

Scroll to top